Regulatory5 May 2026, 07:21 pm

Auro Labs Receives EDQM 'Attestation of Inspection' for Tarapur Facility

AI Summary

Auro Laboratories Ltd. has received an 'Attestation of Inspection' from the European Directorate for the Quality of Medicines & Healthcare (EDQM) for its manufacturing facility at MIDC Tarapur, Maharashtra. The attestation, referencing inspection number INSP 2012-002-P05, confirms compliance with Good Manufacturing Practice (GMP) requirements under EU Rules for CEP Dossier No. CEP 2005-123 /Metformin Hydrochloride.

Key Highlights

Auro Labs receives EDQM 'Attestation of Inspection'.
Inspection confirms GMP compliance under EU Rules.
Facility is located at MIDC Tarapur, Maharashtra.
Attestation relates to Metformin Hydrochloride CEP Dossier.

View BSE Filing

AUROLAB

Pharmaceuticals

AURO LABORATORIES LTD.

Price Impact